QA: Evofem Biosciences Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001618835_2025_Evofem_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001618835, Evofem Biosciences Inc

  xvar xval
0 AssetsCurrent 13,609,000
1 IntangibleAssetsNetIncludingGoodwill 9,597,000
2 PropertyPlantAndEquipmentNet 458,000
3 remainder_Assets 125,000
4 LiabilitiesCurrent 80,448,000
5 LiabilitiesNoncurrent 7,000
6 remainder_Liabilities 9,809,000
7 CostOfGoodsAndServicesSold 4,207,763
8 SellingGeneralAndAdministrativeExpense 11,671,187
9 ResearchAndDevelopmentExpense 2,070,256
10 remainder_Expenses 10,227,655
11 remainder_Revenues 20,874,442
12 remainder_NetIncome 15,917,043
13 remainder_ComprehensiveNetIncome -28,661,849
  yvar yval
0 Assets 23,789,000
1 Liabilities 90,264,000
2 Expenses 28,176,861
3 Revenues 20,874,442
4 StockholdersEquity -66,475,000
5 NetIncome 8,614,624
6 ComprehensiveNetIncome -5,716,300
7 BaseVar 103,841,598
8 EconomicCapitalRatiobeforeLimitedLiability -2.64
9 EconomicCapitalRatio 0.807

Edgar->Model Mapping

Feature Distribution

Change over Time